Title Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing.
Author Kim, Ki Wook; Deveson, Ira W; Pang, Chi Nam I; Yeang, Malinna; Naing, Zin; Adikari, Thiruni; Hammond, Jillian M; Stevanovski, Igor; Beukers, Alicia G; Verich, Andrey; Yin, Simon; McFarlane, David; Wilkins, Marc R; Stelzer-Braid, Sacha; Bull, Rowena A; Craig, Maria E; van Hal, Sebastiaan J; Rawlinson, William D
Journal Sci Rep Publication Year/Month 2021-Feb
PMID 33594223 PMCID PMC7887263
Affiliation + expend 1.School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Accumulating evidence supports the high prevalence of co-infections among Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) patients, and their potential to worsen the clinical outcome of COVID-19. However, there are few data on Southern Hemisphere populations, and most studies to date have investigated a narrow spectrum of viruses using targeted qRT-PCR. Here we assessed respiratory viral co-infections among SARS-CoV-2 patients in Australia, through respiratory virome characterization. Nasopharyngeal swabs of 92 SARS-CoV-2-positive cases were sequenced using pan-viral hybrid-capture and the Twist Respiratory Virus Panel. In total, 8% of cases were co-infected, with rhinovirus (6%) or influenzavirus (2%). Twist capture also achieved near-complete sequencing (> 90% coverage, > tenfold depth) of the SARS-CoV-2 genome in 95% of specimens with Ct < 30. Our results highlight the importance of assessing all pathogens in symptomatic patients, and the dual-functionality of Twist hybrid-capture, for SARS-CoV-2 whole-genome sequencing without amplicon generation and the simultaneous identification of viral co-infections with ease.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.